中国民康医学
中國民康醫學
중국민강의학
MEDICAL JOURNAL OF CHINSEE PEOPLE HEALTH
2014年
21期
20-22
,共3页
杨勇超%李爱玲%张中法%魏红强
楊勇超%李愛玲%張中法%魏紅彊
양용초%리애령%장중법%위홍강
坦度螺酮%帕罗西汀%社交焦虑症
坦度螺酮%帕囉西汀%社交焦慮癥
탄도라동%파라서정%사교초필증
Tandospirone%Paroxetine%Social anxiety disorder
目的::评价坦度螺酮治疗社交焦虑症的疗效和安全性。方法:用坦度螺酮和帕罗西汀进行随机双盲对照观察66例患者。采用Liebowitz社交焦虑量表( LSAS)、副反应量表( TESS)、临床总体印象量表( CGI)评价患者疗效和不良反应,并定期检查患者肝、肾功能、心电图、脑电图、血生化(Glu、K、Na、Cl)等。结果:坦度螺酮对社交焦虑症疗效与帕罗西汀相当,两组患者疗效分别为78.1%,79.4%,(P>0.05)。坦度螺酮的不良反应明显少于帕罗西汀(P<0.01)。结论:坦度螺酮是一种疗效较好、安全性较高的治疗社交焦虑症的药物。
目的::評價坦度螺酮治療社交焦慮癥的療效和安全性。方法:用坦度螺酮和帕囉西汀進行隨機雙盲對照觀察66例患者。採用Liebowitz社交焦慮量錶( LSAS)、副反應量錶( TESS)、臨床總體印象量錶( CGI)評價患者療效和不良反應,併定期檢查患者肝、腎功能、心電圖、腦電圖、血生化(Glu、K、Na、Cl)等。結果:坦度螺酮對社交焦慮癥療效與帕囉西汀相噹,兩組患者療效分彆為78.1%,79.4%,(P>0.05)。坦度螺酮的不良反應明顯少于帕囉西汀(P<0.01)。結論:坦度螺酮是一種療效較好、安全性較高的治療社交焦慮癥的藥物。
목적::평개탄도라동치료사교초필증적료효화안전성。방법:용탄도라동화파라서정진행수궤쌍맹대조관찰66례환자。채용Liebowitz사교초필량표( LSAS)、부반응량표( TESS)、림상총체인상량표( CGI)평개환자료효화불량반응,병정기검사환자간、신공능、심전도、뇌전도、혈생화(Glu、K、Na、Cl)등。결과:탄도라동대사교초필증료효여파라서정상당,량조환자료효분별위78.1%,79.4%,(P>0.05)。탄도라동적불량반응명현소우파라서정(P<0.01)。결론:탄도라동시일충료효교호、안전성교고적치료사교초필증적약물。
Objective:To evaluate efficacy and safety of tandospirone in treatment of social anxiety disorder. Methods:66 so-cial anxiety disorder patients were divided into tandospirone and paroxetine for a random double-blind study. The efficacy and side effects were evaluated with Liebowitzs Social Anxiety Scale ( LSAS) , treatment emergent symptom scale ( TESS) , and clinical global impression scale ( CGI);and then renal function, liver function, electrocardiogram ( ECG) , electroencephalogram ( EEG) , biochemi-cal analysis ( Glu, K, Na, Cl) and the like were tested. Results:The clinical efficacy had no significant difference between tandospi-rone and paroxetine. The effective rates of two groups were separately 78. 1% and 79. 4% (P>0. 05). The side effects of tandospirone were less than those of paroxetine (P<0. 01). Conclusions: Tandospirone is an effective and highly safe drug in the treatment social anxiety disorder.